Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial

20051,039 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 366, Issue 9494, pp. 1367-1374

Field-Weighted Citation Impact: 18.13